Romidepsin for cutaneous T-cell lymphoma.

Future oncology (London, England)

Volumn 9, Issue 12, 2013, Pages 1819-1827

  Prince, H Miles ^a   Dickinson, Michael ^b   Khot, Amit ^b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEPSIPEPTIDE; HISTONE DEACETYLASE INHIBITOR; ROMIDEPSIN;

ARTICLE; CUTANEOUS T CELL LYMPHOMA; DRUG SCREENING; EVALUATION STUDY; FOOD AND DRUG ADMINISTRATION; HUMAN; PATHOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); TUMOR RECURRENCE; UNITED STATES;

CLINICAL TRIALS, PHASE II AS TOPIC; DEPSIPEPTIDES; DRUG EVALUATION; HISTONE DEACETYLASE INHIBITORS; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; NEOPLASM RECURRENCE, LOCAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84903660952     PISSN: None     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.13.220     Document Type: Article

References (0)